ResMed ROE 2006-2019 | RMD

Current and historical return on equity (ROE) values for ResMed (RMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. ResMed ROE for the three months ending September 30, 2019 was 26.72%.
ResMed ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-09-30 $0.42B $2.12B 20.52%
2019-06-30 $0.41B $2.07B 20.38%
2019-03-31 $0.45B $2.02B 22.48%
2018-12-31 $0.45B $1.96B 22.60%
2018-09-30 $0.34B $1.90B 16.70%
2018-06-30 $0.32B $2.06B 15.42%
2018-03-31 $0.31B $2.07B 15.22%
2017-12-31 $0.29B $2.02B 14.51%
2017-09-30 $0.35B $2.05B 18.64%
2017-06-30 $0.34B $1.96B 18.80%
2017-03-31 $0.32B $1.86B 18.43%
2016-12-31 $0.33B $1.71B 19.09%
2016-09-30 $0.35B $1.77B 20.77%
2016-06-30 $0.35B $1.70B 22.23%
2016-03-31 $0.36B $1.67B 22.87%
2015-12-31 $0.36B $1.52B 23.38%
2015-09-30 $0.35B $1.46B 22.81%
2015-06-30 $0.35B $1.59B 22.12%
2015-03-31 $0.35B $1.54B 21.61%
2014-12-31 $0.35B $1.59B 21.05%
2014-09-30 $0.35B $1.65B 20.65%
2014-06-30 $0.35B $1.76B 20.41%
2014-03-31 $0.33B $1.69B 19.96%
2013-12-31 $0.33B $1.64B 19.43%
2013-09-30 $0.32B $1.69B 18.58%
2013-06-30 $0.31B $1.61B 17.98%
2013-03-31 $0.31B $1.77B 18.22%
2012-12-31 $0.29B $1.75B 17.46%
2012-09-30 $0.28B $1.70B 17.04%
2012-06-30 $0.26B $1.61B 16.18%
2012-03-31 $0.24B $1.61B 14.70%
2011-12-31 $0.23B $1.56B 13.84%
2011-09-30 $0.22B $1.55B 13.43%
2011-06-30 $0.23B $1.73B 13.95%
2011-03-31 $0.22B $1.66B 14.64%
2010-12-31 $0.22B $1.61B 15.21%
2010-09-30 $0.21B $1.48B 15.31%
2010-06-30 $0.19B $1.29B 14.96%
2010-03-31 $0.18B $1.33B 14.83%
2009-12-31 $0.17B $1.26B 15.13%
2009-09-30 $0.16B $1.20B 15.04%
2009-06-30 $0.15B $1.12B 14.51%
2009-03-31 $0.13B $0.97B 13.13%
2008-12-31 $0.12B $0.96B 11.93%
2008-09-30 $0.12B $0.97B 11.11%
2008-06-30 $0.11B $1.08B 10.70%
2008-03-31 $0.11B $1.07B 10.91%
2007-12-31 $0.06B $1.02B 6.74%
2007-09-30 $0.07B $0.98B 7.26%
2007-06-30 $0.07B $0.93B 7.82%
2007-03-31 $0.06B $0.87B 7.67%
2006-12-31 $0.10B $0.85B 13.58%
2006-09-30 $0.10B $0.77B 14.18%
2006-06-30 $0.09B $0.74B 14.25%
2006-03-31 $0.08B $0.67B 14.69%
2005-12-31 $0.07B $0.53B 14.63%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $20.909B $2.607B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.763B 27.14
Medtronic (MDT) Ireland $146.524B 20.57
Stryker (SYK) United States $76.003B 25.56
Boston Scientific (BSX) United States $57.941B 27.35
Baxter (BAX) United States $41.222B 25.00
EssilorLuxottica Societe Anonyme (ESLOY) France $33.507B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.830B 18.71
Terumo (TRUMY) Japan $26.321B 32.85
Lonza Group Ag (LZAGY) Switzerland $25.591B 0.00
Coloplast (CLPBY) Denmark $25.229B 40.28
Smith & Nephew SNATS (SNN) United Kingdom $18.758B 0.00
Sunny Optical Technology (SNPTF) China $17.275B 0.00
Insulet (PODD) United States $10.935B 520.23
Bio-Rad Laboratories (BIO) United States $10.601B 50.88
Hill-Rom Holdings (HRC) United States $6.921B 20.39
William Demant Holdings (WILYY) Denmark $6.665B 0.00
Perrigo (PRGO) Ireland $6.539B 12.19
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.074B 41.04
Canopy Growth (CGC) Canada $5.519B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.748B 29.51
ICU Medical (ICUI) United States $3.612B 23.55
Aurora Cannabis (ACB) Canada $3.385B 0.00
Neogen (NEOG) United States $3.373B 56.45
GW Pharmaceuticals (GWPH) United Kingdom $3.275B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.046B 0.00
Quidel (QDEL) United States $2.573B 24.42
National Vision Holdings (EYE) United States $2.139B 48.27
Agios Pharmaceuticals (AGIO) United States $2.014B 0.00
Cardiovascular Systems (CSII) United States $1.492B 0.00
InMode (INMD) Israel $1.468B 0.00
VAREX IMAGING (VREX) United States $1.144B 22.91
AtriCure (ATRC) United States $1.111B 0.00
Aphria (APHA) $1.109B 0.00
Phibro Animal Health (PAHC) United States $0.924B 17.30
NanoString Technologies (NSTG) United States $0.848B 0.00
Lantheus Holdings (LNTH) United States $0.838B 20.93
TG Therapeutics (TGTX) United States $0.794B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.777B 29.74
Omeros (OMER) United States $0.687B 0.00
PetIQ (PETQ) United States $0.686B 16.72
LeMaitre Vascular (LMAT) United States $0.679B 38.13
Quanterix (QTRX) United States $0.631B 0.00
Cerus (CERS) United States $0.609B 0.00
Surmodics (SRDX) United States $0.531B 55.41
HEXO (HEXO) $0.486B 0.00
OraSure Technologies (OSUR) United States $0.485B 29.07
Owens & Minor (OMI) United States $0.414B 15.30
MacroGenics (MGNX) United States $0.410B 0.00
Organigram Holdings (OGI) Canada $0.386B 0.00
Utah Medical Products (UTMD) United States $0.368B 26.68
Meridian Bioscience (VIVO) United States $0.366B 12.59
BioLife Solutions (BLFS) United States $0.302B 122.92
Zynex (ZYXI) United States $0.302B 34.11
Bovie Medical (APYX) United States $0.266B 0.00
Viemed Healthcare (VMD) United States $0.254B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.247B 0.00
United Health Products (UEEC) United States $0.208B 0.00
Vapotherm (VAPO) United States $0.196B 0.00
Repro-Med Systems (KRMD) United States $0.170B 0.00
Cytosorbents (CTSO) United States $0.138B 0.00
Rockwell Medical (RMTI) United States $0.134B 0.00
Fonar (FONR) United States $0.131B 9.23
Female Health (VERU) United States $0.125B 0.00
Chimerix (CMRX) United States $0.114B 0.00
Liberty Health Sciences (LHSIF) Canada $0.113B 0.00
United-Guardian (UG) United States $0.089B 22.60
Chembio Diagnostics (CEMI) United States $0.076B 0.00
Nephros (NEPH) United States $0.066B 0.00
Surface Oncology (SURF) United States $0.052B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.044B 0.00
MTech Acquisition (KERN) United States $0.042B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.022B 0.00
Senestech (SNES) United States $0.018B 0.00
GUARDION HEALTH (GHSI) United States $0.017B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00